TICAGRELOR

TICAGRELOR was reported 32137 times

TICAGRELOR is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 CAPILLARY FRAGILITY TEST 12 0.6316
1 VASCULAR STENT OCCLUSION 151 0.3747
2 VASCULAR STENT THROMBOSIS 732 0.3594
3 VASCULAR STENT RESTENOSIS 28 0.2979
4 VASCULAR STENT STENOSIS 86 0.2043
5 HYPERSENSITIVITY MYOCARDITIS 22 0.1818
6 ARTERIAL RESTENOSIS 19 0.1610
7 PLATELET AGGREGATION INHIBITION 13 0.1413
8 VENTRICULAR ASYSTOLE 20 0.1149
9 THROMBOSIS IN DEVICE 335 0.1021
10 BREATH HOLDING 39 0.1016
11 STENT MALFUNCTION 20 0.1010
12 ECG SIGNS OF MYOCARDIAL ISCHAEMIA 20 0.0877
13 CORONARY ARTERY RESTENOSIS 52 0.0870
14 PLATELET FUNCTION TEST ABNORMAL 19 0.0848
15 SINUS ARREST 115 0.0733
16 MYOCARDIAL RUPTURE 21 0.0689
17 CHEYNE-STOKES RESPIRATION 15 0.0605
18 ACID BASE BALANCE ABNORMAL 12 0.0536
19 CORONARY ARTERY OCCLUSION 598 0.0436
20 CARDIAC VENTRICULAR THROMBOSIS 55 0.0426
21 BLEEDING TIME PROLONGED 50 0.0414
22 VASCULAR OCCLUSION 86 0.0407
23 GASTRODUODENAL ULCER 17 0.0404
24 ANGINA UNSTABLE 259 0.0398
25 CORONARY ARTERY THROMBOSIS 79 0.0391
26 BRONCHIAL HAEMORRHAGE 12 0.0385
27 CORONARY ARTERY DISSECTION 33 0.0384
28 VASCULAR GRAFT OCCLUSION 14 0.0365
29 CORONARY ARTERY STENOSIS 176 0.0350
30 MUSCLE NECROSIS 31 0.0341
31 SINOATRIAL BLOCK 16 0.0268
32 ARTERIAL OCCLUSIVE DISEASE 204 0.0259
33 ACUTE MYOCARDIAL INFARCTION 737 0.0250
34 VENOUS OCCLUSION 45 0.0247
35 ACUTE CORONARY SYNDROME 204 0.0246
36 SUFFOCATION FEELING 59 0.0238
37 RETROPERITONEAL HAEMATOMA 48 0.0217
38 ASPHYXIA 176 0.0215
39 BRADYARRHYTHMIA 34 0.0207
40 CARDIAC STRESS TEST ABNORMAL 17 0.0205
41 CARDIAC ANEURYSM 20 0.0201
42 ACQUIRED HAEMOPHILIA 20 0.0200
43 ELECTROCARDIOGRAM ST SEGMENT ELEVATION 66 0.0199
44 FORCED VITAL CAPACITY DECREASED 13 0.0199
45 STENT PLACEMENT 159 0.0197
46 PROGRESSIVE MULTIPLE SCLEROSIS 22 0.0190
47 ARTERIAL STENOSIS 16 0.0182
48 NOCTURNAL DYSPNOEA 23 0.0180
49 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 158 0.0179
50 VASCULAR PSEUDOANEURYSM 31 0.0178
51 VASOSPASM 16 0.0174
52 LABELLED DRUG-DRUG INTERACTION ISSUE 25 0.0173
53 INFARCTION 118 0.0172
54 ANGINA PECTORIS 493 0.0172
55 PERIPHERAL ARTERY OCCLUSION 24 0.0171
56 RHABDOMYOLYSIS 710 0.0170
57 BLOOD LOSS ANAEMIA 38 0.0168
58 ATRIOVENTRICULAR BLOCK COMPLETE 111 0.0166
59 INTERMITTENT CLAUDICATION 26 0.0164
60 MYOCARDIAL INFARCTION 2804 0.0161
61 SINUS NODE DYSFUNCTION 29 0.0158
62 ORTHOPNOEA 50 0.0157
63 PRODUCT NAME CONFUSION 17 0.0156
64 PERICARDIAL HAEMORRHAGE 34 0.0155
65 ARTERIAL THROMBOSIS 30 0.0155
66 MYOCARDIAL NECROSIS MARKER INCREASED 26 0.0155
67 STENOSIS 29 0.0154
68 HAEMORRHAGE URINARY TRACT 39 0.0153
69 BLOOD CHOLESTEROL DECREASED 28 0.0150
70 SUBCUTANEOUS HAEMATOMA 19 0.0149
71 MYOPATHY 125 0.0145
72 SUBACUTE CUTANEOUS LUPUS ERYTHEMATOSUS 25 0.0140
73 HAEMORRHAGIC DIATHESIS 50 0.0140
74 HAEMORRHAGE INTRACRANIAL 207 0.0138
75 RETROPERITONEAL HAEMORRHAGE 34 0.0138
76 PROCALCITONIN INCREASED 16 0.0136
77 CHOLESTATIC LIVER INJURY 30 0.0135
78 CORONARY ARTERIAL STENT INSERTION 68 0.0134
79 ANGIOPLASTY 20 0.0134
80 BRAIN NATRIURETIC PEPTIDE INCREASED 41 0.0133
81 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 14 0.0132
82 ATRIOVENTRICULAR BLOCK 100 0.0129
83 CARDIAC DISCOMFORT 26 0.0129
84 TRAUMATIC HAEMORRHAGE 24 0.0127
85 BLOOD PRESSURE SYSTOLIC ABNORMAL 31 0.0125
86 MIXED LIVER INJURY 37 0.0123
87 VASCULAR RUPTURE 19 0.0123
88 INCREASED TENDENCY TO BRUISE 112 0.0122
89 BRAIN HERNIATION 36 0.0120
90 TROPONIN T INCREASED 15 0.0118
91 GASTRITIS EROSIVE 55 0.0118
92 DYSPNOEA AT REST 34 0.0117
93 ATRIOVENTRICULAR BLOCK SECOND DEGREE 35 0.0115
94 PULMONARY HAEMORRHAGE 89 0.0114
95 EAR HAEMORRHAGE 23 0.0114
96 DIASTOLIC DYSFUNCTION 35 0.0113
97 CONTUSION 1090 0.0113
98 AORTIC VALVE STENOSIS 20 0.0112
99 CATHETER SITE HAEMORRHAGE 28 0.0112
100 PLATELET DISORDER 28 0.0111
101 LOSS OF CONTROL OF LEGS 42 0.0111
102 DEVICE OCCLUSION 155 0.0110
103 CAROTID ARTERY OCCLUSION 40 0.0110
104 BLOOD CHOLESTEROL ABNORMAL 50 0.0108
105 SUBARACHNOID HAEMORRHAGE 110 0.0108
106 BLOOD PRESSURE DIASTOLIC ABNORMAL 27 0.0106
107 HEPARIN-INDUCED THROMBOCYTOPENIA 52 0.0105
108 ISCHAEMIC CARDIOMYOPATHY 32 0.0104
109 CORONARY ARTERY DISEASE 311 0.0103
110 HAEMORRHAGIC STROKE 80 0.0102
111 SHOCK HAEMORRHAGIC 83 0.0102
112 URINARY BLADDER HAEMORRHAGE 21 0.0100
113 CARDIOGENIC SHOCK 141 0.0098
114 CHRONIC GASTRITIS 22 0.0097
115 COAGULATION TIME PROLONGED 15 0.0097
116 INTRAVENTRICULAR HAEMORRHAGE 24 0.0096
117 MELAENA 211 0.0096
118 UPPER GASTROINTESTINAL HAEMORRHAGE 161 0.0096
119 ESSENTIAL HYPERTENSION 17 0.0093
120 PERIPHERAL ARTERY THROMBOSIS 13 0.0093
121 ANEURYSM 46 0.0092
122 LOWER GASTROINTESTINAL HAEMORRHAGE 68 0.0092
123 DUODENAL ULCER HAEMORRHAGE 26 0.0091
124 IMMUNE-MEDIATED MYOSITIS 25 0.0091
125 TROPONIN INCREASED 69 0.0091
126 NEPHROGENIC ANAEMIA 42 0.0091
127 EPISTAXIS 677 0.0090
128 DIVERTICULUM INTESTINAL HAEMORRHAGIC 20 0.0089
129 POST PROCEDURAL HAEMATOMA 15 0.0089
130 INTRACARDIAC THROMBUS 27 0.0088
131 PULMONARY ALVEOLAR HAEMORRHAGE 49 0.0087
132 GASTRITIS HAEMORRHAGIC 13 0.0087
133 MICROCYTIC ANAEMIA 18 0.0086
134 HAEMATOMA 221 0.0085
135 HAEMORRHAGE 888 0.0085
136 INTRACRANIAL ANEURYSM 34 0.0085
137 ELECTROCARDIOGRAM ABNORMAL 66 0.0084
138 HIGH DENSITY LIPOPROTEIN DECREASED 28 0.0084
139 CEREBELLAR HAEMORRHAGE 12 0.0084
140 VENTRICULAR FIBRILLATION 93 0.0084
141 CEREBRAL HAEMATOMA 28 0.0083
142 HEPATITIS CHOLESTATIC 50 0.0083
143 GASTROINTESTINAL HAEMORRHAGE 684 0.0082
144 GASTROINTESTINAL ULCER 18 0.0081
145 CHEST PAIN 1485 0.0080
146 CARDIAC TAMPONADE 38 0.0080
147 ARTERIOSPASM CORONARY 32 0.0080
148 INTERNAL HAEMORRHAGE 91 0.0080
149 MYOSITIS 71 0.0079
150 SPLENIC RUPTURE 13 0.0079
151 MYOCARDIAL ISCHAEMIA 90 0.0079
152 INTESTINAL POLYP 13 0.0079
153 CEREBRAL HAEMORRHAGE 276 0.0077
154 CHEST DISCOMFORT 789 0.0077
155 ABDOMINAL WALL HAEMATOMA 15 0.0077
156 BLOOD BLISTER 24 0.0077
157 BLOOD URINE PRESENT 144 0.0076
158 CARDIAC FAILURE CHRONIC 32 0.0075
159 RED CELL DISTRIBUTION WIDTH INCREASED 31 0.0075
160 EXTREMITY NECROSIS 13 0.0074
161 BRAIN DEATH 23 0.0074
162 ARTERIOSCLEROSIS 70 0.0074
163 ARTERIAL DISORDER 14 0.0073
164 BODY HEIGHT DECREASED 77 0.0072
165 FAECES DISCOLOURED 156 0.0072
166 DYSPNOEA 4051 0.0071
167 GINGIVAL BLEEDING 97 0.0071
168 EMBOLIC STROKE 25 0.0071
169 THROMBOTIC THROMBOCYTOPENIC PURPURA 25 0.0071
170 DUODENAL ULCER 50 0.0071
171 GASTRIC ULCER HAEMORRHAGE 39 0.0070
172 SMALL INTESTINAL HAEMORRHAGE 14 0.0069
173 PROCEDURAL HAEMORRHAGE 27 0.0069
174 ELECTROCARDIOGRAM ST SEGMENT DEPRESSION 15 0.0068
175 GASTRIC HAEMORRHAGE 78 0.0068
176 WALKING DISABILITY 14 0.0067
177 NON-CARDIAC CHEST PAIN 21 0.0066
178 TACHYPNOEA 90 0.0066
179 IRON DEFICIENCY ANAEMIA 61 0.0066
180 SUBDURAL HAEMORRHAGE 18 0.0066
181 THROMBOCYTOSIS 24 0.0065
182 ARTERIOSCLEROSIS CORONARY ARTERY 43 0.0065
183 HAEMORRHAGE SUBCUTANEOUS 23 0.0065
184 HEPATIC CYTOLYSIS 82 0.0064
185 HYPERPARATHYROIDISM SECONDARY 16 0.0064
186 EJECTION FRACTION DECREASED 99 0.0064
187 GASTRIC ULCER 120 0.0063
188 CAROTID ARTERY STENOSIS 22 0.0063
189 DRUG INTERACTION 997 0.0063
190 GOUT 112 0.0062
191 LARGE INTESTINAL HAEMORRHAGE 14 0.0062
192 DUODENITIS 19 0.0062
193 HAEMATOCRIT INCREASED 14 0.0061
194 DYSPNOEA EXERTIONAL 230 0.0061
195 ULCER HAEMORRHAGE 41 0.0061
196 CARDIAC FLUTTER 39 0.0060
197 BRADYCARDIA 319 0.0060
198 MITRAL VALVE INCOMPETENCE 68 0.0060
199 INTENTIONAL PRODUCT MISUSE 524 0.0060
200 MYELOFIBROSIS 18 0.0059
201 HYPERLIPIDAEMIA 71 0.0059
202 HAEMORRHOIDAL HAEMORRHAGE 29 0.0059
203 VENTRICULAR TACHYCARDIA 98 0.0059
204 PROSTATOMEGALY 23 0.0058
205 HAEMOPTYSIS 163 0.0058
206 SUBDURAL HAEMATOMA 83 0.0058
207 PULSELESS ELECTRICAL ACTIVITY 24 0.0057
208 CARDIAC FAILURE ACUTE 38 0.0057
209 SINUS BRADYCARDIA 55 0.0057
210 PANIC DISORDER 22 0.0057
211 PERIPHERAL ARTERIAL OCCLUSIVE DISEASE 23 0.0056
212 POST PROCEDURAL HAEMORRHAGE 65 0.0056
213 HAEMATURIA 191 0.0056
214 BLOOD URIC ACID INCREASED 32 0.0055
215 LEFT VENTRICULAR DYSFUNCTION 37 0.0055
216 HAEMOTHORAX 16 0.0055
217 VENTRICULAR ARRHYTHMIA 20 0.0055
218 HYPOVOLAEMIC SHOCK 26 0.0054
219 WOUND HAEMORRHAGE 20 0.0054
220 POTENTIATING DRUG INTERACTION 18 0.0054
221 SPINAL STENOSIS 22 0.0053
222 ATRIOVENTRICULAR BLOCK FIRST DEGREE 23 0.0053
223 LOW DENSITY LIPOPROTEIN INCREASED 41 0.0053
224 REBOUND ACID HYPERSECRETION 16 0.0053
225 WOUND COMPLICATION 18 0.0052
226 ANGIOPATHY 29 0.0052
227 EXTRASYSTOLES 36 0.0052
228 SKIN HAEMORRHAGE 76 0.0051
229 DYSLIPIDAEMIA 26 0.0051
230 ACUTE KIDNEY INJURY 779 0.0051
231 HEART RATE DECREASED 178 0.0051
232 CHOLECYSTITIS INFECTIVE 14 0.0050
233 BENIGN PROSTATIC HYPERPLASIA 26 0.0050
234 AORTIC ANEURYSM 38 0.0050
235 ECCHYMOSIS 34 0.0050
236 INABILITY TO AFFORD MEDICATION 49 0.0049
237 LARGE INTESTINE POLYP 34 0.0049
238 HEART VALVE INCOMPETENCE 14 0.0049
239 EXERCISE TOLERANCE DECREASED 28 0.0049
240 ABNORMAL LOSS OF WEIGHT 33 0.0048
241 HAEMATEMESIS 122 0.0048
242 RESPIRATION ABNORMAL 33 0.0048
243 CARDIAC ARREST 395 0.0048
244 BLOOD PRESSURE ABNORMAL 94 0.0047
245 HAEMODYNAMIC INSTABILITY 36 0.0047
246 HIATUS HERNIA 61 0.0047
247 VENTRICULAR HYPOKINESIA 15 0.0047
248 HEART RATE ABNORMAL 26 0.0047
249 MOUTH HAEMORRHAGE 34 0.0046
250 VENTRICULAR EXTRASYSTOLES 48 0.0046
251 PETECHIAE 48 0.0046
252 EYE HAEMORRHAGE 61 0.0046
253 CARDIAC DYSFUNCTION 17 0.0046
254 EOSINOPHILIA 80 0.0046
255 RECTAL HAEMORRHAGE 196 0.0046
256 GLOMERULAR FILTRATION RATE DECREASED 56 0.0046
257 VASCULAR GRAFT 13 0.0045
258 SKIN MASS 30 0.0045
259 ESCHERICHIA URINARY TRACT INFECTION 19 0.0045
260 ACUTE PULMONARY OEDEMA 25 0.0044
261 SLEEP APNOEA SYNDROME 85 0.0044
262 VARICOSE VEIN 23 0.0044
263 THROMBOSIS 356 0.0044
264 IMMUNE THROMBOCYTOPENIA 20 0.0044
265 DIVERTICULUM 31 0.0044
266 BUNDLE BRANCH BLOCK RIGHT 20 0.0044
267 NORMOCHROMIC NORMOCYTIC ANAEMIA 13 0.0043
268 AORTIC STENOSIS 15 0.0043
269 BLOOD PRESSURE SYSTOLIC INCREASED 84 0.0043
270 BLOOD TRIGLYCERIDES INCREASED 76 0.0043
271 PERIPHERAL VASCULAR DISORDER 22 0.0043
272 BLOOD DISORDER 34 0.0042
273 NEAR DEATH EXPERIENCE 14 0.0042
274 FACIAL PARESIS 15 0.0042
275 END STAGE RENAL DISEASE 77 0.0042
276 HEPATIC PAIN 18 0.0042
277 BLOOD PRESSURE FLUCTUATION 101 0.0042
278 LEFT VENTRICULAR HYPERTROPHY 18 0.0042
279 BLOOD PRESSURE DECREASED 277 0.0042
280 EAR DISORDER 19 0.0041
281 HYPERVENTILATION 24 0.0041
282 HAEMOGLOBIN DECREASED 425 0.0041
283 ISCHAEMIA 19 0.0041
284 RALES 24 0.0041
285 BLOOD CHOLESTEROL INCREASED 192 0.0041
286 TONGUE DISCOLOURATION 18 0.0041
287 ISCHAEMIC STROKE 73 0.0041
288 CATHETERISATION CARDIAC 18 0.0041
289 GLUCOSE TOLERANCE IMPAIRED 24 0.0041
290 VIRAL UPPER RESPIRATORY TRACT INFECTION 19 0.0040
291 IMMUNOSUPPRESSANT DRUG LEVEL INCREASED 13 0.0039
292 APPARENT DEATH 14 0.0039
293 SCRATCH 41 0.0039
294 EUGLYCAEMIC DIABETIC KETOACIDOSIS 16 0.0039
295 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 25 0.0038
296 FRUSTRATION TOLERANCE DECREASED 31 0.0038
297 LIVER INJURY 94 0.0038
298 COLITIS MICROSCOPIC 18 0.0038
299 ARRHYTHMIA 179 0.0038
300 CARDIAC DISORDER 353 0.0038
301 CHROMATURIA 84 0.0037
302 HYPOACUSIS 159 0.0037
303 PERIPHERAL ISCHAEMIA 15 0.0037
304 HYPERURICAEMIA 15 0.0036
305 PULMONARY OEDEMA 162 0.0036
306 CARDIAC FAILURE 288 0.0036
307 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 90 0.0035
308 HAEMATOCHEZIA 193 0.0035
309 INTENTIONAL DRUG MISUSE 73 0.0035
310 SKIN ATROPHY 20 0.0035
311 FACE INJURY 13 0.0034
312 RASH MACULO-PAPULAR 76 0.0034
313 HAEMORRHAGIC ANAEMIA 15 0.0034
314 VITAMIN D DECREASED 29 0.0034
315 BLOOD PRESSURE DIASTOLIC DECREASED 25 0.0034
316 OESOPHAGEAL ULCER 13 0.0034
317 MUSCULOSKELETAL DISCOMFORT 58 0.0034
318 ANURIA 29 0.0034
319 PERICARDIAL EFFUSION 77 0.0033
320 HYPERTENSIVE CRISIS 37 0.0033
321 SKIN DISCOLOURATION 152 0.0033
322 BLOOD CREATINE PHOSPHOKINASE INCREASED 95 0.0033
323 DRUG DOSE OMISSION 542 0.0033
324 OBSTRUCTION 13 0.0033
325 MENISCUS INJURY 20 0.0032
326 BLOOD PRESSURE DIASTOLIC INCREASED 15 0.0032
327 GASTRITIS 85 0.0032
328 BLOOD PRESSURE INCREASED 486 0.0032
329 LIMB INJURY 86 0.0032
330 BLOOD CREATINE INCREASED 14 0.0032
331 ANAL ABSCESS 17 0.0032
332 MULTIPLE ORGAN DYSFUNCTION SYNDROME 89 0.0031
333 ATRIAL FIBRILLATION 305 0.0031
334 MOUTH SWELLING 18 0.0031
335 TRANSIENT ISCHAEMIC ATTACK 105 0.0031
336 CEREBRAL ISCHAEMIA 16 0.0031
337 CEREBRAL DISORDER 23 0.0031
338 DIZZINESS POSTURAL 30 0.0031
339 LACERATION 29 0.0031
340 HEPATITIS ACUTE 20 0.0031
341 MUSCLE FATIGUE 13 0.0031
342 OLIGURIA 19 0.0031
343 TORSADE DE POINTES 24 0.0031
344 AORTIC VALVE INCOMPETENCE 13 0.0031
345 HEART RATE IRREGULAR 69 0.0031
346 CEREBROVASCULAR ACCIDENT 517 0.0030
347 TRICUSPID VALVE INCOMPETENCE 24 0.0030
348 COAGULOPATHY 50 0.0030
349 ANAL FISTULA 16 0.0030
350 OROPHARYNGEAL DISCOMFORT 27 0.0030
351 ORTHOSTATIC HYPOTENSION 52 0.0030
352 SKIN TIGHTNESS 14 0.0030
353 URINE OUTPUT DECREASED 26 0.0030
354 VITAMIN D DEFICIENCY 29 0.0030
355 CHRONIC KIDNEY DISEASE 224 0.0029
356 PULSE ABSENT 14 0.0029
357 SUPRAVENTRICULAR TACHYCARDIA 28 0.0029
358 PRODUCT USE ISSUE 547 0.0029
359 HYPOVOLAEMIA 17 0.0029
360 COLD SWEAT 51 0.0029
361 IRON DEFICIENCY 13 0.0029
362 ATRIAL FLUTTER 23 0.0029
363 METABOLIC ACIDOSIS 92 0.0029
364 TYPE 2 DIABETES MELLITUS 96 0.0028
365 ANAEMIA 542 0.0028
366 OESOPHAGITIS 31 0.0028
367 DRUG-INDUCED LIVER INJURY 89 0.0028
368 DIABETES MELLITUS 216 0.0028
369 BLOOD PRESSURE INADEQUATELY CONTROLLED 17 0.0028
370 CHOLECYSTITIS ACUTE 16 0.0028
371 ABSCESS LIMB 12 0.0028
372 HYPERCHOLESTEROLAEMIA 27 0.0028
373 INGUINAL HERNIA 17 0.0028
374 SYNCOPE 279 0.0028
375 PERFORMANCE STATUS DECREASED 13 0.0028
376 RENAL CYST 22 0.0028
377 DIABETES MELLITUS INADEQUATE CONTROL 49 0.0028
378 PRESYNCOPE 67 0.0028
379 HYPOKINESIA 40 0.0028
380 HYDROCEPHALUS 15 0.0028
381 THYROID DISORDER 42 0.0027
382 INTESTINAL ISCHAEMIA 15 0.0027
383 TUBULOINTERSTITIAL NEPHRITIS 51 0.0027
384 HEAD INJURY 86 0.0027
385 APNOEA 21 0.0027
386 PERIPHERAL COLDNESS 37 0.0027
387 POST-TRAUMATIC STRESS DISORDER 18 0.0027
388 HYPOTENSION 532 0.0026
389 HEMIPLEGIA 22 0.0026
390 BLOOD PRESSURE SYSTOLIC DECREASED 12 0.0026
391 HAEMORRHOIDS 51 0.0026
392 SHOCK 60 0.0026
393 OVERWEIGHT 14 0.0026
394 CHOLESTASIS 50 0.0026
395 TOOTHACHE 47 0.0026
396 MEMORY IMPAIRMENT 355 0.0026
397 ELECTROLYTE IMBALANCE 30 0.0026
398 MULTIPLE ALLERGIES 20 0.0025
399 DIZZINESS 1272 0.0025
400 SLUGGISHNESS 26 0.0025
401 RENAL TUBULAR NECROSIS 25 0.0025
402 CHOKING SENSATION 14 0.0025
403 PROSTATIC DISORDER 14 0.0025
404 FEELING ABNORMAL 606 0.0025
405 BRONCHOSPASM 36 0.0025
406 GASTROOESOPHAGEAL REFLUX DISEASE 203 0.0025
407 COLITIS ISCHAEMIC 17 0.0025
408 ASTHENIA 937 0.0025
409 WEIGHT FLUCTUATION 26 0.0025
410 BLOOD CREATININE INCREASED 162 0.0025
411 COMPLICATION ASSOCIATED WITH DEVICE 36 0.0025
412 MUSCLE DISORDER 20 0.0025
413 DIARRHOEA HAEMORRHAGIC 23 0.0025
414 CONCUSSION 19 0.0025
415 CARDIAC VALVE DISEASE 14 0.0024
416 POLYP 16 0.0024
417 BODY TEMPERATURE DECREASED 24 0.0024
418 HEMIPARESIS 41 0.0024
419 DECREASED ACTIVITY 26 0.0024
420 WEIGHT DECREASED 672 0.0024
421 HYPERTENSION 506 0.0024
422 COUGH 669 0.0024
423 GLYCOSYLATED HAEMOGLOBIN INCREASED 60 0.0024
424 BRAIN OEDEMA 30 0.0024
425 PURPURA 21 0.0024
426 HAEMATOCRIT DECREASED 47 0.0024
427 RENAL PAIN 25 0.0024
428 PULMONARY CONGESTION 31 0.0023
429 FEAR 63 0.0023
430 PHARYNGEAL OEDEMA 36 0.0023
431 LEUKAEMIA 22 0.0023
432 BLOOD UREA INCREASED 39 0.0023
433 CARDIAC OPERATION 20 0.0023
434 RASH GENERALISED 60 0.0023
435 HYPOPHAGIA 59 0.0023
436 THINKING ABNORMAL 43 0.0023
437 DERMATITIS ALLERGIC 29 0.0023
438 SWOLLEN TONGUE 72 0.0023
439 THERAPY CESSATION 118 0.0023
440 TOXIC SKIN ERUPTION 23 0.0023
441 MENTAL IMPAIRMENT 55 0.0023
442 OBESITY 36 0.0023
443 DEAFNESS 59 0.0023
444 PANIC ATTACK 82 0.0022
445 NEPHROLITHIASIS 102 0.0022
446 NERVOUSNESS 116 0.0022
447 LIPASE INCREASED 17 0.0022
448 MASS 31 0.0022
449 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 115 0.0022
450 VISUAL ACUITY REDUCED 73 0.0022
451 PALPITATIONS 257 0.0022
452 SCAB 25 0.0022
453 DEVICE DISLOCATION 95 0.0022
454 HYPERTRANSAMINASAEMIA 15 0.0022
455 DISTURBANCE IN ATTENTION 116 0.0021
456 RENAL DISORDER 100 0.0021
457 NODULE 28 0.0021
458 BRADYPHRENIA 14 0.0021
459 CARDIOTOXICITY 19 0.0021
460 TOOTH INFECTION 28 0.0021
461 SKIN LACERATION 23 0.0021
462 MUSCULAR WEAKNESS 240 0.0021
463 HEART RATE INCREASED 209 0.0021
464 BLOOD IRON DECREASED 25 0.0021
465 HYPOTONIA 21 0.0021
466 DRUG RESISTANCE 54 0.0021
467 NEUTROPENIC SEPSIS 15 0.0021
468 TOOTH FRACTURE 23 0.0021
469 RENAL FAILURE 276 0.0021
470 ABNORMAL FAECES 17 0.0021
471 PLATELET COUNT INCREASED 27 0.0021
472 ACTIVITIES OF DAILY LIVING IMPAIRED 41 0.0021
473 ERUCTATION 40 0.0021
474 EATING DISORDER 44 0.0021
475 UROSEPSIS 19 0.0021
476 MALAISE 899 0.0020
477 DYSPEPSIA 201 0.0020
478 THROMBOCYTOPENIA 228 0.0020
479 THERAPY CHANGE 20 0.0020
480 MYALGIA 345 0.0020
481 PALLOR 55 0.0020
482 HAEMOGLOBIN ABNORMAL 13 0.0020
483 SINUS DISORDER 40 0.0020
484 CLOSTRIDIUM DIFFICILE INFECTION 44 0.0020
485 DEATH 1734 0.0020
486 SPUTUM DISCOLOURED 19 0.0020
487 PANCREATITIS ACUTE 45 0.0020
488 FATIGUE 1558 0.0020
489 CHOKING 39 0.0020
490 CIRCULATORY COLLAPSE 34 0.0020
491 HEPATITIS 51 0.0020
492 BASAL CELL CARCINOMA 31 0.0020
493 EMPHYSEMA 20 0.0020
494 SEASONAL ALLERGY 28 0.0020
495 HEAD DISCOMFORT 35 0.0020
496 PRODUCT PRESCRIBING ISSUE 43 0.0020
497 GAIT DISTURBANCE 377 0.0020
498 DECUBITUS ULCER 16 0.0020
499 INSURANCE ISSUE 30 0.0020
500 LIVER FUNCTION TEST ABNORMAL 57 0.0020
501 HICCUPS 16 0.0019
502 MUSCULOSKELETAL PAIN 102 0.0019
503 ROTATOR CUFF SYNDROME 25 0.0019
504 ANGIOEDEMA 86 0.0019
505 SPINAL OSTEOARTHRITIS 17 0.0019
506 RED BLOOD CELL COUNT DECREASED 55 0.0019
507 CARDIAC FAILURE CONGESTIVE 154 0.0019
508 INSOMNIA 510 0.0019
509 LOSS OF CONSCIOUSNESS 245 0.0019
510 BRAIN INJURY 19 0.0019
511 CARDIO-RESPIRATORY ARREST 79 0.0019
512 HEPATIC STEATOSIS 35 0.0019
513 HEPATIC FUNCTION ABNORMAL 70 0.0019
514 LIMB DISCOMFORT 58 0.0019
515 PNEUMONITIS 51 0.0019
516 SNEEZING 42 0.0019
517 ACUTE RESPIRATORY FAILURE 36 0.0019
518 SENSORY LOSS 15 0.0019
519 BLOOD MAGNESIUM DECREASED 16 0.0019
520 HYPERKALAEMIA 65 0.0019
521 CATARACT 109 0.0018
522 ULCER 29 0.0018
523 PAIN IN EXTREMITY 536 0.0018
524 SCIATICA 29 0.0018
525 HAEMOLYSIS 14 0.0018
526 CARDIOVASCULAR DISORDER 46 0.0018
527 BONE DISORDER 33 0.0018
528 AGEUSIA 45 0.0018
529 RESPIRATORY RATE INCREASED 16 0.0018
530 DEMENTIA 50 0.0018
531 QUALITY OF LIFE DECREASED 24 0.0018
532 BREAST MASS 12 0.0018
533 ALANINE AMINOTRANSFERASE INCREASED 109 0.0018
534 LIVER FUNCTION TEST INCREASED 38 0.0018
535 DRUG PRESCRIBING ERROR 34 0.0018
536 AMNESIA 115 0.0018
537 GAIT INABILITY 59 0.0018
538 FACIAL PARALYSIS 15 0.0018
539 NECK PAIN 98 0.0018
540 OFF LABEL USE 1534 0.0018
541 EAR PAIN 34 0.0017
542 PULMONARY MASS 26 0.0017
543 GALLBLADDER DISORDER 31 0.0017
544 LUNG DISORDER 85 0.0017
545 MUSCLE STRAIN 15 0.0017
546 NOCTURIA 21 0.0017
547 OXYGEN SATURATION DECREASED 97 0.0017
548 TASTE DISORDER 35 0.0017
549 MIDDLE INSOMNIA 32 0.0017
550 ASPARTATE AMINOTRANSFERASE INCREASED 91 0.0017
551 LIP SWELLING 57 0.0017
552 ABDOMINAL DISCOMFORT 287 0.0017
553 COMA 81 0.0017
554 CONTRAINDICATED PRODUCT ADMINISTERED 51 0.0017
555 TENDONITIS 26 0.0017
556 HAEMARTHROSIS 15 0.0017
557 HYPOALBUMINAEMIA 13 0.0017
558 SLEEP DISORDER 118 0.0017
559 PROSTATIC SPECIFIC ANTIGEN INCREASED 23 0.0017
560 ANAL INCONTINENCE 15 0.0017
561 SARS-COV-2 TEST POSITIVE 22 0.0017
562 BLOOD POTASSIUM INCREASED 27 0.0017
563 GASTRIC DISORDER 57 0.0017
564 BACK DISORDER 27 0.0017
565 SPEECH DISORDER 87 0.0017
566 LEUKOCYTOSIS 30 0.0017
567 HEPATIC ENZYME INCREASED 113 0.0017
568 EAR DISCOMFORT 17 0.0017
569 ATELECTASIS 16 0.0017
570 RIB FRACTURE 34 0.0017
571 CONFUSIONAL STATE 267 0.0017
572 PULMONARY THROMBOSIS 18 0.0016
573 PERIPHERAL SWELLING 254 0.0016
574 FALL 548 0.0016
575 THROMBOTIC MICROANGIOPATHY 16 0.0016
576 CEREBRAL INFARCTION 40 0.0016
577 BACK PAIN 380 0.0016
578 PRODUCT ADMINISTRATION ERROR 33 0.0016
579 RETINAL DETACHMENT 15 0.0016
580 BLOOD THYROID STIMULATING HORMONE INCREASED 15 0.0016
581 CARDIOMYOPATHY 24 0.0016
582 TRANSPLANT REJECTION 13 0.0016
583 HYPERHIDROSIS 209 0.0016
584 FLATULENCE 92 0.0016
585 FEELING COLD 45 0.0016
586 CHOLELITHIASIS 53 0.0016
587 VERTIGO 98 0.0016
588 HERNIA 31 0.0016
589 DEVICE MALFUNCTION 112 0.0016
590 SQUAMOUS CELL CARCINOMA 15 0.0016
591 DISCOMFORT 97 0.0016
592 VISUAL IMPAIRMENT 197 0.0016
593 DEPRESSED MOOD 84 0.0016
594 DIVERTICULITIS 44 0.0016
595 DYSSTASIA 46 0.0016
596 TRANSAMINASES INCREASED 35 0.0016
597 RASH MACULAR 55 0.0016
598 BOWEL MOVEMENT IRREGULARITY 12 0.0016
599 ABDOMINAL PAIN UPPER 322 0.0016
600 ANXIETY 445 0.0016
601 LOWER LIMB FRACTURE 30 0.0016
602 HELICOBACTER INFECTION 16 0.0016
603 RENAL IMPAIRMENT 130 0.0015
604 INTENTIONAL DOSE OMISSION 44 0.0015
605 DENTAL CARIES 17 0.0015
606 HYPOAESTHESIA 230 0.0015
607 MENORRHAGIA 30 0.0015
608 TINNITUS 70 0.0015
609 PRODUCT DOSE OMISSION 99 0.0015
610 OSTEOPENIA 23 0.0015
611 PLEURAL EFFUSION 92 0.0015
612 CHOLECYSTITIS 18 0.0015
613 DYSPHONIA 88 0.0015
614 ERYTHEMA MULTIFORME 14 0.0015
615 WHEEZING 89 0.0015
616 SKIN LESION 41 0.0015
617 DECREASED APPETITE 347 0.0015
618 BALANCE DISORDER 129 0.0015
619 DISSEMINATED INTRAVASCULAR COAGULATION 21 0.0015
620 APHASIA 45 0.0015
621 GENERAL PHYSICAL HEALTH DETERIORATION 172 0.0015
622 TOOTH DISORDER 33 0.0015
623 PAIN IN JAW 42 0.0015
624 ARTHRITIS 116 0.0015
625 TOOTH ABSCESS 15 0.0015
626 INTENTIONAL PRODUCT USE ISSUE 129 0.0015
627 RESPIRATORY DEPRESSION 18 0.0015
628 ABNORMAL WEIGHT GAIN 18 0.0015
629 RESPIRATORY FAILURE 106 0.0015
630 ERECTILE DYSFUNCTION 37 0.0014
631 NERVE INJURY 16 0.0014
632 POLLAKIURIA 60 0.0014
633 IMPAIRED HEALING 47 0.0014
634 PHARYNGEAL SWELLING 14 0.0014
635 HYPERSOMNIA 41 0.0014
636 DYSPHAGIA 135 0.0014
637 INCONTINENCE 15 0.0014
638 LIGAMENT SPRAIN 14 0.0014
639 BRAIN NEOPLASM 13 0.0014
640 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 24 0.0014
641 INCREASED APPETITE 27 0.0014
642 BLOOD ALKALINE PHOSPHATASE INCREASED 35 0.0014
643 WHITE BLOOD CELL COUNT INCREASED 54 0.0014
644 MOVEMENT DISORDER 45 0.0014
645 BLINDNESS 57 0.0014
646 BLOOD POTASSIUM DECREASED 42 0.0014
647 MUSCLE SPASMS 256 0.0014
648 NEPHROPATHY 13 0.0014
649 DISORIENTATION 55 0.0014
650 CARDIAC MURMUR 12 0.0014
651 BLOOD COUNT ABNORMAL 21 0.0014
652 PRODUCTIVE COUGH 66 0.0014
653 HYPERTHYROIDISM 20 0.0014
654 BRONCHITIS 102 0.0014
655 DRY THROAT 14 0.0014
656 DRUG INTOLERANCE 133 0.0014
657 VASCULITIS 16 0.0014
658 GASTROENTERITIS 20 0.0014
659 PLATELET COUNT DECREASED 146 0.0014
660 EYE DISORDER 45 0.0014
661 MUSCULOSKELETAL DISORDER 26 0.0014
662 HYPOXIA 48 0.0014
663 ELECTROCARDIOGRAM QT PROLONGED 49 0.0014
664 APHONIA 19 0.0014
665 MUSCLE TIGHTNESS 22 0.0014
666 RED BLOOD CELL SEDIMENTATION RATE INCREASED 15 0.0014
667 DRUG ERUPTION 24 0.0014
668 BLOOD TEST ABNORMAL 19 0.0014
669 HYPERBILIRUBINAEMIA 14 0.0014
670 STEVENS-JOHNSON SYNDROME 30 0.0013
671 URINARY RETENTION 45 0.0013
672 BLINDNESS UNILATERAL 19 0.0013
673 C-REACTIVE PROTEIN INCREASED 49 0.0013
674 OSTEOARTHRITIS 57 0.0013
675 PRURITUS GENERALISED 29 0.0013
676 MACULAR DEGENERATION 16 0.0013
677 DRUG ADMINISTRATION ERROR 41 0.0013
678 PARALYSIS 19 0.0013
679 JOINT DISLOCATION 14 0.0013
680 LOCALISED INFECTION 32 0.0013
681 IMPAIRED GASTRIC EMPTYING 18 0.0013
682 HYPERSENSITIVITY 245 0.0013
683 FOOT FRACTURE 25 0.0013
684 LOCAL SWELLING 23 0.0013
685 ROAD TRAFFIC ACCIDENT 55 0.0013
686 RENAL INJURY 39 0.0013
687 BREAST PAIN 14 0.0013
688 NASAL CONGESTION 77 0.0013
689 DRUG DISPENSING ERROR 20 0.0013
690 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 44 0.0013
691 POOR QUALITY SLEEP 28 0.0013
692 PULMONARY HYPERTENSION 27 0.0013
693 THROAT TIGHTNESS 35 0.0013
694 BLOOD GLUCOSE INCREASED 243 0.0013
695 APPENDICITIS 12 0.0013
696 HYPOTHYROIDISM 41 0.0013
697 TACHYCARDIA 114 0.0013
698 ANAPHYLACTIC SHOCK 33 0.0013
699 UNRESPONSIVE TO STIMULI 33 0.0013
700 DRUG LEVEL DECREASED 13 0.0013
701 DRUG LEVEL INCREASED 21 0.0013
702 JAUNDICE 34 0.0013
703 VISION BLURRED 173 0.0013
704 WEIGHT INCREASED 282 0.0013
705 TOOTH LOSS 26 0.0013
706 DYSURIA 46 0.0012
707 NASOPHARYNGITIS 230 0.0012
708 TRANSFUSION 13 0.0012
709 HEADACHE 772 0.0012
710 THERAPY NON-RESPONDER 55 0.0012
711 ILLNESS 126 0.0012
712 ADVERSE EVENT 112 0.0012
713 COLON CANCER 18 0.0012
714 DEHYDRATION 161 0.0012
715 UPPER LIMB FRACTURE 24 0.0012
716 RESPIRATORY DISORDER 36 0.0012
717 EMOTIONAL DISORDER 37 0.0012
718 DIALYSIS 17 0.0012
719 TOXIC EPIDERMAL NECROLYSIS 18 0.0012
720 AGITATION 87 0.0012
721 LETHARGY 68 0.0012
722 MEDICATION ERROR 65 0.0012
723 SKIN DISORDER 39 0.0012
724 OROPHARYNGEAL PAIN 108 0.0012
725 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 56 0.0012
726 DIARRHOEA 751 0.0012
727 MUSCULOSKELETAL CHEST PAIN 18 0.0012
728 LUNG INFECTION 18 0.0012
729 INTERNATIONAL NORMALISED RATIO INCREASED 33 0.0012
730 BLOOD CALCIUM DECREASED 13 0.0012
731 RESTLESS LEGS SYNDROME 21 0.0012
732 PNEUMONIA 372 0.0011
733 CONDITION AGGRAVATED 349 0.0011
734 SEPSIS 128 0.0011
735 RESTLESSNESS 42 0.0011
736 URTICARIA 192 0.0011
737 FLUID RETENTION 58 0.0011
738 CARDIOMEGALY 14 0.0011
739 MICTURITION URGENCY 13 0.0011
740 HYPONATRAEMIA 64 0.0011
741 GENERALISED OEDEMA 14 0.0011
742 PERICARDITIS 19 0.0011
743 ACUTE RESPIRATORY DISTRESS SYNDROME 20 0.0011
744 RASH ERYTHEMATOUS 54 0.0011
745 HEPATOCELLULAR INJURY 16 0.0011
746 RETCHING 24 0.0011
747 JOINT INJURY 24 0.0011
748 IRRITABLE BOWEL SYNDROME 24 0.0011
749 NEURALGIA 27 0.0011
750 WOUND 31 0.0011
751 PARAESTHESIA 174 0.0011
752 LIVER DISORDER 49 0.0011
753 UPPER RESPIRATORY TRACT INFECTION 51 0.0011
754 PRODUCT DISPENSING ERROR 24 0.0011
755 DEPRESSION 250 0.0011
756 INTERVERTEBRAL DISC PROTRUSION 24 0.0011
757 ASTHMA 124 0.0011
758 NAUSEA 867 0.0011
759 BLOOD GLUCOSE FLUCTUATION 12 0.0011
760 DYSGEUSIA 81 0.0011
761 ARTHRALGIA 453 0.0011
762 RESPIRATORY DISTRESS 30 0.0011
763 JOINT SWELLING 131 0.0011
764 TREMOR 180 0.0011
765 RHINORRHOEA 70 0.0011
766 BLOOD GLUCOSE DECREASED 52 0.0011
767 URINARY INCONTINENCE 32 0.0011
768 SWELLING 101 0.0011
769 IMPAIRED WORK ABILITY 23 0.0011
770 PRURITUS 413 0.0011
771 PAIN 660 0.0011
772 CARPAL TUNNEL SYNDROME 15 0.0011
773 RASH PRURITIC 58 0.0011
774 THROAT IRRITATION 48 0.0011
775 SOMNOLENCE 215 0.0011
776 CONSTIPATION 232 0.0011
777 PHOTOPHOBIA 20 0.0011
778 ABDOMINAL DISTENSION 111 0.0011
779 GASTROINTESTINAL DISORDER 95 0.0011
780 SEPTIC SHOCK 46 0.0011
781 SYNOVITIS 19 0.0011
782 TENDON RUPTURE 13 0.0011
783 INFLUENZA 117 0.0010
784 RASH 457 0.0010
785 SKIN ULCER 27 0.0010
786 POST PROCEDURAL COMPLICATION 20 0.0010
787 DIABETIC KETOACIDOSIS 25 0.0010
788 FEEDING DISORDER 21 0.0010
789 ANKLE FRACTURE 16 0.0010
790 FEELING HOT 63 0.0010
791 MUSCULOSKELETAL STIFFNESS 90 0.0010
792 LACRIMATION INCREASED 31 0.0010
793 OEDEMA PERIPHERAL 125 0.0010
794 AGRANULOCYTOSIS 19 0.0010
795 HALLUCINATION 77 0.0010
796 ABDOMINAL PAIN 235 0.0010
797 ANGER 34 0.0010
798 CYSTITIS 32 0.0010
799 PRODUCT USE IN UNAPPROVED INDICATION 249 0.0010
800 INJECTION SITE BRUISING 80 0.0010
801 SWELLING FACE 65 0.0010
802 OSTEOMYELITIS 18 0.0010
803 PRODUCT DOSE OMISSION IN ERROR 28 0.0010
804 LYMPHADENOPATHY 35 0.0010
805 VOMITING 464 0.0010
806 GLAUCOMA 19 0.0010
807 SKIN EXFOLIATION 83 0.0010
808 CELLULITIS 49 0.0010
809 ALTERED STATE OF CONSCIOUSNESS 21 0.0010
810 HYPOGLYCAEMIA 47 0.0010
811 EYE SWELLING 36 0.0010
812 NEOPLASM MALIGNANT 64 0.0010
813 OEDEMA 52 0.0010
814 DYSARTHRIA 36 0.0010
815 ARTHROPATHY 53 0.0010
816 TREATMENT NONCOMPLIANCE 52 0.0009
817 INFLAMMATION 49 0.0009
818 SPINAL FRACTURE 19 0.0009
819 LOWER RESPIRATORY TRACT INFECTION 43 0.0009
820 FEELING JITTERY 18 0.0009
821 RESPIRATORY TRACT CONGESTION 15 0.0009
822 MENTAL DISORDER 41 0.0009
823 ANAPHYLACTIC REACTION 52 0.0009
824 COVID-19 165 0.0009
825 MENTAL STATUS CHANGES 26 0.0009
826 ADVERSE DRUG REACTION 84 0.0009
827 HIP FRACTURE 30 0.0009
828 ABASIA 23 0.0009
829 PRODUCT DOSE OMISSION ISSUE 273 0.0009
830 BLISTER 52 0.0009
831 JOINT STIFFNESS 24 0.0009
832 DRY MOUTH 74 0.0009
833 THERAPY INTERRUPTED 65 0.0009
834 HYPERGLYCAEMIA 33 0.0009
835 VIRAL INFECTION 30 0.0009
836 NIGHT SWEATS 29 0.0009
837 LACTIC ACIDOSIS 29 0.0009
838 BRAIN FOG 14 0.0009
839 SINUSITIS 91 0.0009
840 BONE PAIN 52 0.0009
841 BURNING SENSATION 62 0.0009
842 SEIZURE 102 0.0009
843 CHILLS 103 0.0009
844 URINARY TRACT INFECTION 149 0.0009
845 NEUROPATHY PERIPHERAL 83 0.0009
846 NIGHTMARE 30 0.0009
847 FIBROMYALGIA 21 0.0009
848 GAMMA-GLUTAMYLTRANSFERASE INCREASED 19 0.0009
849 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 154 0.0009
850 HEPATOTOXICITY 19 0.0009
851 LUNG NEOPLASM MALIGNANT 35 0.0009
852 EYE PAIN 48 0.0008
853 ORAL PAIN 19 0.0008
854 HYPOKALAEMIA 39 0.0008
855 DISEASE RECURRENCE 40 0.0008
856 PRODUCT PRESCRIBING ERROR 20 0.0008
857 RESPIRATORY ARREST 23 0.0008
858 PULMONARY EMBOLISM 79 0.0008
859 CYANOSIS 13 0.0008
860 THERAPEUTIC RESPONSE UNEXPECTED 37 0.0008
861 ILL-DEFINED DISORDER 50 0.0008
862 SCAR 14 0.0008
863 FREQUENT BOWEL MOVEMENTS 22 0.0008
864 HOT FLUSH 61 0.0008
865 DISABILITY 16 0.0008
866 ERYTHEMA 166 0.0008
867 CRYING 29 0.0008
868 ABNORMAL DREAMS 22 0.0008
869 FULL BLOOD COUNT DECREASED 16 0.0008
870 COLITIS 30 0.0008
871 GASTRIC CANCER 20 0.0008
872 PROTEINURIA 15 0.0008
873 PHOTOSENSITIVITY REACTION 13 0.0008
874 IRRITABILITY 47 0.0008
875 INFECTION 113 0.0008
876 DELIRIUM 27 0.0008
877 GASTROENTERITIS VIRAL 14 0.0008
878 HEPATIC FAILURE 23 0.0008
879 MOUTH ULCERATION 16 0.0008
880 OCULAR HYPERAEMIA 36 0.0008
881 PANCREATITIS 40 0.0008
882 MULTI-ORGAN FAILURE 13 0.0008
883 PRESCRIBED UNDERDOSE 15 0.0008
884 BACTERIAL INFECTION 14 0.0007
885 PRODUCT PHYSICAL ISSUE 15 0.0007
886 MOOD ALTERED 20 0.0007
887 RHEUMATOID ARTHRITIS 83 0.0007
888 HERPES ZOSTER 42 0.0007
889 MOBILITY DECREASED 52 0.0007
890 VAGINAL HAEMORRHAGE 31 0.0007
891 KIDNEY INFECTION 14 0.0007
892 LABORATORY TEST ABNORMAL 21 0.0007
893 INJECTION SITE MASS 26 0.0007
894 PRODUCT AVAILABILITY ISSUE 16 0.0007
895 MUSCLE TWITCHING 16 0.0007
896 THERAPEUTIC RESPONSE DECREASED 42 0.0007
897 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 49 0.0007
898 PROCEDURAL PAIN 19 0.0007
899 DEPRESSED LEVEL OF CONSCIOUSNESS 27 0.0007
900 OSTEOPOROSIS 28 0.0007
901 FLUSHING 69 0.0007
902 OSTEONECROSIS 22 0.0007
903 DRUG INEFFECTIVE 882 0.0007
904 INTESTINAL OBSTRUCTION 25 0.0007
905 STOMATITIS 40 0.0007
906 DIPLOPIA 17 0.0007
907 SKIN CANCER 14 0.0006
908 BLOOD GLUCOSE ABNORMAL 12 0.0006
909 GYNAECOMASTIA 20 0.0006
910 INJURY 45 0.0006
911 STAPHYLOCOCCAL INFECTION 21 0.0006
912 DEEP VEIN THROMBOSIS 41 0.0006
913 SUICIDAL IDEATION 56 0.0006
914 THERAPEUTIC RESPONSE SHORTENED 20 0.0006
915 INJECTION SITE HAEMORRHAGE 48 0.0006
916 INCORRECT PRODUCT ADMINISTRATION DURATION 13 0.0006
917 COGNITIVE DISORDER 28 0.0006
918 UNEVALUABLE EVENT 45 0.0006
919 PYREXIA 204 0.0006
920 FEMUR FRACTURE 18 0.0006
921 RASH PAPULAR 13 0.0006
922 RESPIRATORY TRACT INFECTION 15 0.0006
923 PSYCHOTIC DISORDER 17 0.0006
924 THERAPEUTIC PRODUCT EFFECT DECREASED 25 0.0006
925 INTERSTITIAL LUNG DISEASE 27 0.0006
926 PAIN OF SKIN 15 0.0006
927 ECZEMA 29 0.0006
928 PSORIASIS 70 0.0005
929 DRY SKIN 71 0.0005
930 SURGERY 31 0.0005
931 ALOPECIA 102 0.0005
932 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 105 0.0005
933 EXPIRED PRODUCT ADMINISTERED 17 0.0005
934 INCORRECT DRUG ADMINISTRATION DURATION 14 0.0005
935 SEDATION 13 0.0005
936 COMPLETED SUICIDE 41 0.0005
937 HOSPITALISATION 75 0.0005
938 BLOOD BILIRUBIN INCREASED 13 0.0005
939 NERVOUS SYSTEM DISORDER 15 0.0005
940 FUNGAL INFECTION 16 0.0005
941 SYSTEMIC LUPUS ERYTHEMATOSUS 17 0.0005
942 MIGRAINE 45 0.0005
943 MOOD SWINGS 15 0.0005
944 EYE IRRITATION 27 0.0005
945 ANHEDONIA 12 0.0005
946 INCORRECT DOSE ADMINISTERED 103 0.0005
947 INFLUENZA LIKE ILLNESS 37 0.0004
948 EYE PRURITUS 15 0.0004
949 PSORIATIC ARTHROPATHY 18 0.0004
950 AGGRESSION 22 0.0004
951 PANCYTOPENIA 24 0.0004
952 EXTRA DOSE ADMINISTERED 17 0.0004
953 PRODUCT SUBSTITUTION ISSUE 24 0.0004
954 DRUG EFFECT INCOMPLETE 15 0.0004
955 RENAL FAILURE ACUTE 17 0.0004
956 DISEASE PROGRESSION 47 0.0004
957 TREATMENT FAILURE 32 0.0004
958 COLITIS ULCERATIVE 17 0.0004
959 ABNORMAL BEHAVIOUR 15 0.0004
960 MULTIPLE SCLEROSIS 18 0.0004
961 SUICIDE ATTEMPT 22 0.0004
962 DRY EYE 18 0.0004
963 BLADDER CANCER 21 0.0004
964 DYSKINESIA 14 0.0003
965 NO ADVERSE EVENT 61 0.0003
966 UNDERDOSE 24 0.0003
967 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 18 0.0003
968 PROSTATE CANCER 26 0.0003
969 ACNE 24 0.0003
970 NEUTROPENIA 43 0.0003
971 DEVICE ISSUE 28 0.0003
972 WHITE BLOOD CELL COUNT DECREASED 33 0.0003
973 PRODUCT QUALITY ISSUE 40 0.0003
974 TOXICITY TO VARIOUS AGENTS 49 0.0003
975 EMOTIONAL DISTRESS 35 0.0003
976 INFUSION RELATED REACTION 19 0.0003
977 INJECTION SITE PAIN 83 0.0003
978 INTENTIONAL OVERDOSE 16 0.0002
979 SKIN BURNING SENSATION 17 0.0002
980 INJECTION SITE ERYTHEMA 29 0.0002
981 DEVICE DIFFICULT TO USE 15 0.0002
982 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 16 0.0002
983 INJECTION SITE PRURITUS 15 0.0002
984 OVERDOSE 48 0.0002
985 PRODUCT STORAGE ERROR 19 0.0002
986 INJECTION SITE SWELLING 16 0.0002
987 MALIGNANT NEOPLASM PROGRESSION 21 0.0002
988 FEBRILE NEUTROPENIA 13 0.0002
989 DRUG DOSE OMISSION BY DEVICE 15 0.0002
990 DRUG ABUSE 13 0.0002
991 BREAST CANCER 12 0.0001
992 ACCIDENTAL EXPOSURE TO PRODUCT 12 0.0001